Magnesium Glycinate 600mg + B6 50mg, 12-Week PMDD -42% Mood Swings -38%
WELLNESS

Magnesium Glycinate 600mg + B6 50mg, 12-Week PMDD -42% Mood Swings -38%

By Sophie · · American Journal of Obstetrics and Gynecology
KO | EN

A 12-week RCT of magnesium glycinate 600mg + vitamin B6 50mg combination simultaneously improving PMDD scores and mood swings in women aged 25~45 with PMDD diagnosis has been published. The clinical position of neurotransmitter and serotonin synthesis molecules has been re-validated.

Clinical Data

A double-blind RCT in 160 women aged 25~45 with PMDD diagnosis randomized 1:1 to magnesium glycinate 600mg + B6 50mg/day or placebo. After 12 weeks, the primary endpoint was DRSP (Daily Record of Severity of Problems), secondary endpoints were PSS-10, abdominal bloating, and pain.

The magnesium + B6 arm showed:

  • DRSP total score -42% (p<0.001)
  • Mood swings -38%
  • Abdominal bloating -32%
  • Headache -28%
  • Breast tenderness -24%
  • Sweet cravings -36%

Placebo arm showed only typical -8~12% placebo response.

Mechanism: Two-Molecule Synergy

PMDD is brain hypersensitivity to hormonal fluctuations. Core mechanism:

  • Luteal phase progesterone/estrogen fluctuation
  • Serotonin/GABA neurotransmission instability
  • Magnesium deficiency increases neuronal excitability
  • B6 deficiency reduces serotonin/dopamine synthesis

Magnesium (NMDA + GABA):

  • NMDA receptor block → reduced neural excitation
  • GABA enhancement → calming, sleep
  • Uterine smooth muscle relaxation → pain reduction
  • Daily recommended 320mg, PMDD 600mg+

Vitamin B6 (Pyridoxine):

  • Tryptophan → serotonin conversion (PLP cofactor)
  • Dopamine/norepinephrine synthesis
  • Homocysteine metabolism
  • Daily recommended 1.5mg, PMS 50~100mg

Combined: neural stabilization + neurotransmitter normalization simultaneously.

Magnesium Form Differences

Magnesium form determines absorption and PMDD efficacy:

Magnesium glycinate - clinical standard

  • 80%+ absorption (highest)
  • Glycine itself has calming effect
  • Minimal GI irritation
  • First-line for PMDD, sleep, anxiety

Magnesium citrate

  • 70% absorption
  • Mild laxative effect (helpful for constipation)
  • Most common form

Magnesium oxide - not recommended

  • 4~10% absorption
  • Strong laxative effect
  • Insufficient clinical efficacy

Magnesium L-threonate

  • Crosses blood-brain barrier (cognition)
  • Expensive, limited PMDD data

For PMDD, magnesium glycinate 600mg is first-line.

B6 Safety Dosing

Vitamin B6 carries neuropathy risk with chronic high-dose use. Safety guide:

  • PMS/PMDD: 50~100mg/day for 12 weeks~6 months
  • Long-term: 25~50mg/day maintenance
  • Risk dose: 200mg+ chronic (peripheral neuropathy)
  • Stop immediately: hand/foot numbness, tingling

P5P (pyridoxal 5-phosphate, active form) is safer and more effective than regular pyridoxine. Standardization: P5P 25~50mg.

Clinical Indications

Beyond PMS/PMDD, magnesium + B6 multi-axis effects:

  • Migraine -28% (magnesium alone + B6 synergy)
  • Pregnancy nausea -34%
  • Carpal tunnel syndrome -22%
  • Hypertension -8~12% (magnesium alone)
  • Insulin sensitivity +14%

Clinical Application

  • Standard dose: magnesium glycinate 600mg + B6 50mg/day
  • Timing: start luteal phase (14 days before period), stop or maintain at period
  • Split dose: morning 200mg + evening 400mg (sleep aid)
  • Absorption: with meals
  • Caution: kidney impairment (magnesium accumulation risk)
  • Side effects: loose stool, drowsiness (rare at appropriate doses)
  • Synergistic matrix: calcium + saffron + vitex + omega-3